`
`From:
`Sent:
`To:
`Cc:
`Subject:
`Attachments:
`
`Dowd, Matthew J <MatthewDowd@andrewskurth.com>
`Thursday, March 31, 2016 5:39 PM
`Reister, Andrea
`Crotty, Justin; Robbins, Jennifer L; Longton, Rick
`Inter Partes Review IPR No. 2016-00204
`90013709 - 2016.03.30 notice of incomplete request.pdf
`
`Andrea:
`
`For your convenience, I provide a copy of the 30-day Notice concerning the ex parte reexamination request.
`
` I
`
` understand that you left a voice message with Thomas MacAllister, CEO of Argentum. If the call concerns a legal
`matter relating to the current dispute, I ask that you contact me. Mr. MacAllister is interested in having a business
`conversation with the relevant people at UCB. Could you please provide the contact information so arrangements can
`be made to talk?
`
`Best regards,
`
`Matthew J. Dowd
`Partner
`
`Andrews Kurth LLP
`1350 I Street, NW, Suite 1100
`Washington, DC 20005
`202.662.2701 Phone
`202.974.9511 Fax
`202.573.3853 Cell
`MatthewDowd@andrewskurth.com
`vCard | Bio | andrewskurth.com | Twitter | Facebook
`
`
`
`Confidentiality Notice: The information contained in this email and any attachments to it may be legally privileged and
`include confidential information intended only for the recipient(s) identified above. If you are not one of those intended
`recipients, you are hereby notified that any dissemination, distribution or copying of this email or its attachments is strictly
`prohibited. If you have received this email in error, please notify the sender of that fact by return email and permanently
`delete the email and any attachments to it immediately. Please do not retain, copy or use this email or its attachments for
`any purpose, nor disclose all or any part of its contents to any other person. Andrews Kurth LLP operates as a limited
`liability partnership. Andrews Kurth (Middle East) DMCC is registered and licensed as a Free Zone company under the
`rules and regulations of DMCCA. Andrews Kurth (UK) LLP is authorized and regulated by the Solicitors Regulation
`Authority of England and Wales (SRA Registration No.598542). Thank you.
`
`1
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2032 - 1/1